107. If [F1NHS England] decides to select a proposal for an LPS scheme for development, it must give notice of that decision and provide such details of the proposed LPS scheme as it considers appropriate to—
(a)the HWB (HWB1) for the area in which are situated the premises at or from which local pharmaceutical services are to be provided under the proposal;
(b)any Local Pharmaceutical Committee for the area in which are situated the premises at or from which local pharmaceutical services are to be provided under the proposal;
(c)any Local Medical Committee for the area in which are situated the premises at or from which local pharmaceutical services are to be provided under the proposal;
(d)any NHS chemist whose listed chemist premises—
(i)are in the area of HWB1, or
(ii)are in the area of a neighbouring HWB and whose interests are likely, in the opinion of [F1NHS England], to be affected by the proposal;
(e)any person who is entitled because of the grant of a routine or excepted application to be included in a pharmaceutical list—
(i)for the area of HWB1, or
(ii)for the area of a neighbouring HWB, if their interests are likely, in the opinion of [F1NHS England], to be affected by the proposal,
but who is not (yet) included;
(f)any LPS chemist whose scheme premises—
(i)are in the area of HWB1, or
(ii)are in the area of a neighbouring HWB and whose interests are likely, in the opinion of [F1NHS England], to be affected by the proposal;
(g)any dispensing doctor whose listed dispensing premises—
(i)are in the area of HWB1, or
(ii)are in the area of a neighbouring HWB and whose interests are likely, in the opinion of [F1NHS England], to be affected by the proposal; and
(h)any Local Healthwatch organisation for the area of HWB1.
Textual Amendments
F1Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1